Searched for
SANOFI STOCK
Dividend alert! Last day to buy HDFC Bank, Tata Motors PV, 14 other stocks for dividends worth Rs 248Under SEBI's T+1 settlement cycle, investors must purchase a company's shares at least one trading day before the record date to ensure the...- Inside Cursor's journey to a $60 billion deal with Elon Musk’s SpaceXSpaceX has acquired AI coding assistant Cursor for $60 billion in an all-stock deal, significantly bolstering its AI ambitions. This move p...
- Dividends and bonus issues: 31 stocks turning ex-record date this week. Do you own any?As many as 31 companies, including HDFC Bank, Tata group firms and Brigade Enterprises, will turn ex-record date for dividends and bonus is...
- Molecule glue drugs shake up cancer care, draw big moneyHarvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsOver the next few sessions, as the uncertainty caused by the Gulf war intensifies and makes you anxious, remember this: It is not the first...
- Bonus issue, stock split, dividend: 9 stocks to turn ex-record date next week, check detailsRail Vikas Nigam Limited shares rose 6% after securing a ₹967 crore railway order, strengthening its order book and boosting investor senti...
- Sunil Singhania-backed Abakkus Small Cap Fund first portfolio out since NFO; 42 stocks held, Karur Vysya Bank top betSunil Singhania backed Abakkus Mutual Fund has unveiled the maiden portfolio of its smallcap fund - Abakkus Small Cap Fund, following an in...
- Sanofi Consumer Healthcare lists on stock exchanges after demerger, shares hit 5% upper circuit on day 1Shares of Sanofi Consumer Healthcare India made their market debut on Friday, listing on both the NSE and BSE. On its first day of trading,...
- Novavax soars 146% on $1.2 billion Sanofi vaccine licensing dealThe pact links two big players in the vaccine world that both missed out on the rush to develop and commercialize Covid shots quickly durin...
- Sanofi India board OKs demerger of consumer health businessDrug firm Sanofi India on Wednesday said its board has approved the demerger of its consumer healthcare business into a separate entity. Th...
- Hold Sanofi India, target price Rs 6270: ICICI DirectSanofi India, incorporated in the year 1956, is a Mid Cap company (having a market cap of Rs 13505.73 Crore) operating in Pharmaceuticals s...
- Buy Sanofi India, target price Rs 9250: Sharekhan by BNP ParibasSanofi reported strong results for Q1CY22 with operating margins expanding 139 bps y-o-y and were better than estimated, leading to a PAT a...
- Sanofi India skids 2% on poor earnings scorecardSanofi India’s counter fell to a low of Rs 7,159 as against the previous close of Rs 7,280.40 on the National Stock Exchange.
- Sanofi's valuations are attractive: Why it is stock pick of weekSanofi India’s management has adopted cost control measures and has lowered promotional spends, which was visible in 2020. Its digital push...
- Sanofi India shares hit 52-week high on Q4 resultsThe stock witnessed similar movement on the NSE as well, where it opened at 7,549.95.
- Analysts slash Sanofi target over Ankleshwar plant saleThe stock ended flat at ₹5,928 on Friday.
- Sanofi India stock likely to be re-rated on company's improving fundamentalsHowever, unlike other multinational pharmaceutical companies, Sanofi India was not analysts’ favourite for quite some time.
- Sanofi-Aventis likely to buy Genzyme for USD 19 bn: ReportFrench drug maker Sanofi-Aventis is likely to make an formal offer to acquire US-based biotech company Genzyme for USD 19 billion, says a m...
- Sun's EPS may take a knock if it stops cancer drug saleThe stock of Sun Pharma fell for a fourth day in a row, as investors are worried about the company's legal tussle with Sanofi-Aventis over ...
- Sanofi-Aventis revises open offer for Aventis PharmaThe schedule of Sanofi-Aventis' open offer for shareholders of Aventis Pharma Ltd has been revised by DSP Merrill Lynch, manager of the off...
Load More
